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A B S T R A C T
Aim: The aim was to examine risk factors for hearing impairment among Hispanic/Latino adults with
diabetes.
Methods: Findings are based on 3384 participants aged 18–76 years with diagnosed or previously un-
detected diabetes who completed audiometric testing as part of the Hispanic Community Health Study/
Study of Latinos. We deﬁned hearing impairment as the pure-tone average (PTA) >25 decibels hearing
level [dB HL] of pure-tone thresholds at high frequencies (3000, 4000, 6000, and 8000 Hz) in the worse
ear and deﬁned a second hearing impairment outcome with the additional requirement of PTA >25 dB
HL of low/mid-frequency (500, 1000, and 2000 Hz) thresholds in the worse ear. We identiﬁed indepen-
dent associations using logistic regression.
Results: Controlling for age and Hispanic/Latino background, prevalence ratios for hearing impairment
in the high plus low/mid frequencies were 1.35 (95% CI 1.07, 1.71) for current smoking, 1.64 (1.14, 2.38)
for alcohol consumption (≥14 drinks/week for men or ≥ 7 drinks/week for women), and 1.29 (1.06, 1.56)
for triglycerides ≥ 150 mg/dL. For high-frequency only hearing impairment, the prevalence ratio for es-
timated glomerular ﬁltration rate 30–59 mL/min/1.73 m2 was 1.23 (1.03, 1.47) adjusted for age and sex.
People with family income less than $20,000 had almost twice the prevalence of hearing impairment
(PR = 1.93 (1.34, 2.78)) as people with income over $40,000.
Conclusions: Current smoking, alcohol consumption, high triglycerides, and chronic kidney disease are
potentially preventable correlates of hearing impairment for persons with diabetes. Low income is a marker
of increased likelihood of hearing impairment.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Hearing impairment affects two-thirds of United States (U.S.)
adults with diabetes limiting their ability to communicate with
others [1]. Because an association between diabetes and hearing im-
pairment has been observed among Hispanic/Latino adults [2,3],
among whom one-ﬁfth has diabetes [4], a large number of Hispanic/
Latino adults may be at risk for hearing loss and its possible longer-
term sequelae such as reduced health-related quality of life [5].
Among people with diabetes, hearing loss is thought to be of sen-
sorineural origin, but the pathophysiological mechanisms have not
been determined [6,7]. Diabetic complications, including coro-
nary heart disease and nephropathy, have been associated with
hearing impairment [8,9], and some evidence suggest that
dyslipidemia, speciﬁcally low high-density lipoprotein cholesterol
(HDL) [8], is associated with hearing impairment among people with
diabetes. Other cardiovascular disease risk factors such as hyper-
tension [10], smoking [2], and central adiposity [2] have been
associated with hearing loss, but not speciﬁcally among adults with
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diabetes. Although level of glycemia has been associatedwith hearing
impairment in Japanese [11] and U.S. community-based studies [12],
its relationship to hearing loss in persons with diabetes is incon-
clusive [8,13].
The Hispanic Community Health Study/Study of Latinos (HCHS/
SOL), a large, population-based cohort study of Hispanic/Latino adults
residing in the United States, offers a unique opportunity to examine
metabolic and cardiovascular correlates of hearing impairment
among people with diabetes. The aim of this study was to examine
whether hearing impairment was associated with cardiovascular
disease, potentially modiﬁable cardiovascular risk factors, diabet-
ic complications, and indicators of diabetes severity.
Subjects
Baseline data were collected between 2008 and 2011 as part of
the Hispanic Community Health Study/Study of Latinos (HCHS/
SOL), a multi-site population-based cohort study, with the target
population designed to be all non-institutionalized Hispanic/
Latino adults aged 18–74 years from geographically-deﬁned
communities in the Bronx, Chicago, Miami, and San Diego. Study
design, rationale, and implementation have been reported in detail
[14,15]. Brieﬂy, stratiﬁed two-stage probability sampling for each
site was implemented to generate a diverse sample with respect
to Hispanic ethnicity and socio-economic status. A subsampling pro-
tocol produced an over-representation of adults 45–74 years of age.
Of the 16,415 adults aged 18–74 years at screening, 15,526 (94.6%)
had suﬃcient baseline audiometric data to be eligible for analy-
sis; of those, 3384 individuals had diagnosed (n = 2151) or previously
undetected (n = 1233) diabetes. Institutional review boards at each
participating center approved the study protocol. Participants pro-
vided informed consent.
Materials and methods
Hearing impairment
Audiometric pure-tone air conduction hearing thresholds in deci-
bels (hearing level) [dB HL] were obtained by certiﬁed and trained
technicians for each ear at 500, 1000, 2000, 3000, 4000, 6000, and
8000 Hz using calibrated GSI-61clinical audiometers with TDH-50
headphones in sound-attenuating booths. The protocol was a modi-
ﬁed Hughson–Westlake procedure in accordance with the American
Speech Language Association guidelines [16].
For each individual and ear, we averaged pure-tone thresholds
measured at 500, 1000, and 2000 Hz to produce a pure-tone average
(PTA), as a measure of low/mid-frequency hearing sensitivity. We
averaged pure-tone thresholds measured at 3000, 4000, 6000, and
8000 Hz to produce a PTA as a measure of high-frequency hearing
sensitivity. By deﬁning hearing impairment based on the PTA in
the worse ear, we identiﬁed participants with impairment in at
least one ear. A PTA greater than 25 dB HL deﬁned hearing impair-
ment of at least mild severity, consistent with previous reports on
diabetes and hearing [1,8]. In this cohort, less than 1% percent of
persons with diabetes had a low/mid-frequency hearing impair-
ment without high-frequency involvement. We deﬁned two
outcomes: high-frequency hearing impairment (PTA > 25 dB HL of
pure-tone thresholds measured at 3000, 4000, 6000, and 8000 Hz)
and a combined high-frequency plus low/mid-frequency hearing
impairment which included the subset who also had PTA > 25 dB
HL of pure tone thresholds measured at 500, 1000, and 2000 Hz.
We did not consider low/mid-frequency hearing impairment alone
as an outcome.
Diabetes and related characteristics
Diagnosed diabetes was based on self-report of medically-
diagnosed diabetes (other than during pregnancy) at baseline. Among
persons with no diagnosed diabetes, previously undetected diabe-
tes was deﬁned by indicators of glucosemetabolism: a fasting plasma
glucose ≥126 mg/dl, a 2-hour postload plasma glucose ≥200 mg/
dl, or HbA1c ≥6.5% [17]. Plasma glucose was measured by a
hexokinase enzymatic method (Roche Diagnostics, Indianapolis, IN).
Family history of diabetes was deﬁned as a parent or sibling with
diabetes. Diabetes duration was deﬁned for those with previously
diagnosed diabetes from self-reported age at diagnosis. HbA1c was
assessed in whole blood using a Tosoh G7 Automated High Perfor-
mance Liquid Chromatography Analyzer (Tosoh Bioscience, Inc.,
South San Francisco, CA). Glycemic control was deﬁned as HbA1c
<7% [18]. Reported use of glycemic medications was validated from
prescriptions brought to the interview. Reported use of glycemic
medications that was not validated (n = 12) resulted in a missing
value.
Covariate deﬁnitions
Age, gender, Hispanic background (Mexican, Cuban, Puerto Rican,
Dominican, Central American, South American), marital status, edu-
cational level, and annual family income were ascertained by
questionnaire in English or Spanish. Cigarette use was categorized
as never, former (among those who had smoked 100 cigarettes in
a lifetime), and current. Alcohol consumption was categorized ac-
cording to gender-speciﬁc number of drinks/week. Males who
consumed ≥14 drinks per week and females who consumed ≥7
drinks per week were considered at high risk for developing an
alcohol use disorder [19]. Former drinkers were categorized sepa-
rately from non-drinkers, because former drinkers might represent
people who had a past level of consumption consistent with high
alcohol use disorder risk. Leisure-time noise exposure was as-
sessed by asking whether, outside of work, the participant had been
exposed to loud noise (such as from power tools or loud music) for
an average of at least once per month for a year. Degree of current
occupational noise exposure was assessed by asking during what
proportion of work time it was necessary to speak in a raised voice
to be heard.
The HCHS/SOL measured multiple cardiovascular disease risk
factors: body mass index (BMI), calculated as weight in kilograms
divided by height in meters squared; central adiposity, deﬁned as
a waist measurement ≥102 cm for men or ≥88 cm for women; hy-
pertension, deﬁned as systolic blood pressure ≥140mmHg, diastolic
blood pressure ≥90 mm Hg, or report of current antihypertensive
medication use [20]; serum HDL cholesterol (HDL) measured using
a direct magnesium/dextran sulfate method (Roche Diagnostics, In-
dianapolis, IN) and low HDL cholesterol deﬁned as HDL < 40 mg/
dL for males and <50 mg/dL for females in accordance with the
current standards of medical care [20]; serum LDL cholesterol (LDL)
categorized as <100, 100–129, 130–159, and ≥160mg/dL [21]; total
serum cholesterol, measured using a cholesterol oxidase enzymat-
ic method (Roche Diagnostics, Indianapolis, IN) and categorized with
cutpoints ≥200 and ≥240 mg/dL [21]; serum triglycerides mea-
sured on a Roche Modular P Chemistry analyzer using a glycerol
blanking enzymatic method (Roche Diagnostics, Indianapolis, IN)
and high triglycerides deﬁned as ≥150 mg/dL [20,21]. Two com-
posite cholesterol measures were examined. Adverse cholesterol was
deﬁned as total serum cholesterol ≥240 mg/dL, LDL cholesterol
≥160mg/dL, HDL cholesterol <40mg/dL or use of lipid-loweringmed-
ication conﬁrmed during interview. Dyslipidemia was deﬁned as
any of HDL <40mg/dL, LDL ≥160mg/dL, or triglycerides ≥ 150mg/dL.
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Stage of chronic kidney disease was based on estimated glo-
merular ﬁltration rate [22] with cutpoints: ≥90 mL/min/1.73 m2
(normal), 60–89 mL/min/1.73 m2 (mild), 30–59 mL/min/1.73 m2
(moderate), and <30 mL/min/1.73 m2 (severe or end-stage). Coro-
nary heart disease was assessed by participant report of whether
they had been told by a medical professional that they had coro-
nary heart disease or if they reported a history of coronary
revascularization. Participants also reported whether they had cere-
brovascular disease (or carotid revascularization). Intermittent
claudicationwas determined from report of pain or discomfort when
walking among those 45 years or older. Ankle brachial index (ABI),
the ratio of systolic blood pressure of either the posterior tibial or
the dorsalis pedis artery in the right or left ankle to that of the cor-
responding brachial artery, was assessed in persons aged 45–74 years.
ABI cutpoints were deﬁned as <0.90 (low), 0.90–0.99 (borderline),
1.00–1.39 (normal), and ≥1.4 (high) for each leg. Peripheral arteri-
al disease was deﬁned as an ankle brachial index <0.90 in either leg.
High ABI was deﬁned as an ankle brachial index ≥1.4 in either leg.
Otherwise, borderline and normal ABI were based on the minimum
of the left and right side [23].
Statistical methods
Age is strongly correlated with hearing impairment and with the
majority of the cardiovascular disease risk factors. To control for the
confounding effect of age in the bivariable analysis, we computed
age-standardized prevalence estimates of high-frequency hearing
impairment and high-frequency plus low/mid-frequency hearing
impairment (the combined outcome) for each stratum of the in-
dependent variables. Our method was a direct standardization to
the U.S. standard population from the year 2000 with the follow-
ing age groups: 18–26, 27–35, 36–44, 45–49, 50–54, 55–59, 60–
64, 65–69, and 70–74 years. Age eligibility for intermittent
claudication and ankle brachial index began at 45 years, thus we
used ﬁve year age groups beginning with 45–49 years for the age
standardization. Because few participants younger than 45 years had
chronic kidney disease, cardiovascular disease, or cerebrovascular
disease, we used the same truncated series of age groups for the
age standardization. Age-standardized prevalence estimates were
stratiﬁed by socio-demographic factors, diabetic complications and
characteristics (e.g. disease duration and glycemic medication use),
and cardiovascular disease risk factors. We used a logit transfor-
mation to compute 95% conﬁdence limits to maintain the range
between 0 and 1; signiﬁcant differences were identiﬁed by non-
overlapping conﬁdence limits. Characteristics independently
associated with a greater prevalence of hearing impairment were
identiﬁed from prevalence odds ratios and 95% conﬁdence inter-
vals estimated from multiple logistic regression models. Because
prevalence odds ratios are poor estimates of risk ratios for common
outcomes [24], adjusted prevalence ratios and 95% conﬁdence limits
were computed as a function of average marginal predictions [25],
which allows for comparisons of predicted outcomes between groups
and controls for differences in covariate distributions [26]. Analy-
ses were performed using SAS version 9.4 (SAS corporation, Cary,
NC) and SUDAAN version 11.0.0 (Research Triangle Institute, Re-
search Triangle Park, NC) incorporating sample weights, which were
calibrated to age, gender, and Hispanic/Latino background distri-
butions from the 2010 U.S. census. These sample weights accounted
for the complex sample design and the probability of differential
non-response.
Results
Characteristics of the HCHS/SOL study population with diabe-
tes are presented in Table 1. Over one-third (37.3%) of the study
population was of Mexican background, 22.2% was Cuban and
Table 1
Age standardizeda weighted prevalence of hearing impairment among people with diabetes age 18–76 years by socio-demographic characteristics (Hispanic Community
Health Study/Study of Latinos, n = 3384)
Prevalence (95% CI)
Socio-demographic characteristic Weighted %
High-frequencyb
(n = 1870)
High-frequency plus
low/mid-frequencyc (n = 655)
All, mean age = 53.8 years (unadjusted) 100.0 59.3 (56.6, 61.9) 21.6 (19.2, 24.1)
Hispanic/Latino group (%)
Mexican 37.3 37.0 (33.8, 40.3) 11.3 (9.1 , 14.0)
Cuban 22.2 34.6 (30.1, 39.3) 11.4 (8.8 , 14.7)
Puerto Rican 20.2 40.6 (34.4, 47.1) 17.1 (12.9 , 22.4)
Dominican 10.1 40.4 (30.7, 50.8) 9.9 (6.0 , 16.0)
Central American 6.9 37.9 (30.7, 45.7) 9.0 (6.8 , 11.7)
South American 3.3 Not estimatedd Not estimatedd
Sex (%)
Female 54.5 32.0 (28.8, 35.3) 12.7 (10.1 , 15.8)
Male 45.5 44.8 (40.6, 49.1) 11.8 (9.9 , 14.0)
Marital status (%)
Single 21.5 40.7 (35.7, 45.9) 13.6 (11.5 , 16.0)
Married/living with partner 52.0 36.4 (33.4, 39.5) 12.3 (10.1 , 14.9)
Separated, divorced, or widowed 26.4 34.6 (29.1, 40.6) 10.9 (8.4 , 14.0)
Educational level (%)
Less than high school 45.6 40.8 (36.6, 45.1) 13.0 (11.2 , 15.1)
High school graduate 22.6 38.1 (32.3, 44.1) 12.4 (8.8 , 17.2)
More than high school 31.8 35.2 (31.3, 39.2) 9.9 (7.4 , 13.1)
Annual family income, $ (%)
<20,000 54.3 39.6 (35.7, 43.8) 14.8 (12.0 , 18.1)
20,000–40,000 30.6 37.7 (33.7, 42.0) 10.9 (8.4 , 14.1)
>40,000 15.1 30.9 (25.7, 36.7) 7.1 (5.2 , 9.6)
a Age standardized to 18–26, 27–35, 36–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74 years.
b PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear.
c PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear and PTA(500, 1000, 2000) >25 dB in the worse ear.
d Age-standardized estimates not estimated due to insuﬃcient data.
CI = Conﬁdence Interval.
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one-ﬁfth (20.2%) was Puerto-Rican. The mean age was 53.8 years,
54.5% were female, and over one-half (52.0%) was married or living
with a partner. The majority (45.6%) had less than a high school ed-
ucation and over half (54.3%) had an annual family income of less
than $20,000.
Table 1 gives unadjusted prevalence estimates for high-
frequency and the combined (high- plus low/mid-frequency) hearing
impairment and age-standardized prevalence estimates for these
outcomes by socio-demographic characteristics. Among all Hispanic/
Latino adults with diabetes, we observed a 59.3% (n = 1870)
unadjusted prevalence of high-frequency hearing impairment and
a 21.6% (n = 655) unadjusted prevalence of high-frequency plus
low/mid-frequency hearing impairment (the combined outcome).
Adults of Puerto Rican background had a signiﬁcantly greater
prevalence of high- plus low/mid-frequency hearing loss than
those of Central American background. Due to the age distribu-
tion of the South American subgroup which was skewed older,
age-standardized prevalence estimates could not be computed.
Males with diabetes had a signiﬁcantly greater prevalence of
high-frequency hearing impairment than females, but this sex
difference did not manifest among those with low/mid-frequency
hearing impairment. We observed a strong association between
family income and the combined high- plus low/mid-frequency
hearing impairment. The age-standardized prevalence among those
with annual family income less than $20,000 was twice the
prevalence of those in the upper income category (14.8% versus
7.1%). A similar pattern was also found for educational level. We
observed no prevalence difference by leisure-time or occupational
noise exposure (data not shown).
Frequency differences in characteristics and complications of di-
abetes are provided in Table 2. Slightly less than half (48.8%) of
Hispanic/Latino adults with diabetes had evidence of mild chronic
kidney disease. Hispanic/Latino adults with diabetes who also had
moderate chronic kidney disease had a signiﬁcantly greater age-
standardized prevalence of high-frequency hearing impairment than
people with mild chronic kidney disease or normal kidney func-
tion. Chronic kidney disease was not associated with the combined
high- plus low/mid-frequency hearing impairment. Ten percent of
these Hispanic/Latino adults reported having coronary heart disease,
and 7.7% reported cerebrovascular disease. Over one-third (34%) re-
ported symptoms of intermittent claudication and 7.8% had
peripheral arterial disease.We found no greater prevalence of hearing
Table 2
Age-standardizeda weighted prevalence of hearing impairment among people with diabetes age 18–76 years by diabetic complications and characteristics (Hispanic Com-
munity Health Study/Study of Latinos, n = 3384)
Prevalence (95% CI)
Diabetic complications and characteristics Weighted %
High-frequencyb
(n = 1870)
High-frequency plus
low/mid-frequencyc (n = 655)
Chronic kidney disease (%)§
Normal (eGFR ≥ 90 mL/min/1.73 m2) 39.1 64.1 (60.6, 67.5) 24.0 (20.7, 27.5)
Mild (eGFR 60–89 mL/min/1.73 m2) 48.8 61.9 (58.2, 65.5) 22.5 (19.4, 26.1)
Moderate (eGFR 30–59 mL/min/1.73 m2) 10.9 78.6 (68.0, 86.4) 33.7 (23.4, 45.9)
Severe/End-Stage (eGFR< 30 mL/min/1.73 m2) 1.1 84.4 (60.9, 95.0) 20.40 (10.1, 36.9)
Coronary heart disease§ (%)
No 90.0 64.0 (61.4, 66.5) 23.5 (20.9, 26.3)
Yes 10.0 64.2 (54.6, 72.8) 24.0 (18.4, 30.6)
Cerebrovascular disease§ (%)
No 92.3 64.1 (61.6, 66.5) 23.7 (21.0, 26.5)
Yes 7.7 68.3 (57.1, 77.7) 24.4 (17.6, 32.8)
Intermittent claudication§ (%)
No 65.8 64.1 (61.2, 66.9) 21.8 (19.3, 24.5)
Yes 34.2 63.9 (59.3, 68.2) 27.0 (22.3, 32.2)
Ankle Brachial Index§ (%)
Low/Peripheral arterial disease 7.8 64.2 (56.8, 71.0) 26.2 (18.6, 35.5)
Borderline 14.9 63.8 (58.2, 69.2) 27.4 (22.4, 33.1)
Normal 75.8 63.7 (60.8, 66.4) 22.2 (19.6, 25.0)
High 1.6 78.1 (60.5, 89.3) 24.6 (15.3, 37.0)
Previously diagnosed diabetes (%)
No 37.0 37.4 (34.0, 41.0) 12.1 (9.7, 15.1)
Yes 63.0 38.4 (34.9, 42.1) 12.1 (10.0, 14.6)
Family history of diabetes (%)
No 39.2 39.4 (35.2, 43.8) 12.2 (9.8, 15.1)
Yes 60.8 37.5 (34.2, 40.9) 12.5 (10.4, 15.0)
Among the previously diagnosed with diabetes (n = 2151)
Diabetes duration, years
≤ 3 33.5 41.1 (35.8, 46.6) 12.4 (8.9, 17.0)
>3–5 13.8 36.6 (31.0, 42.6) 10.1 (7.5, 13.5)
>5–10 21.4 36.4 (29.9, 43.5) 13.2 (9.3, 18.3)
>10 31.3 33.1 (27.9, 38.9) 11.2 (9.4, 13.4)
A1c<7% (%)
No 46.7 38.1 (34.7, 41.5) 12.9 (10.7, 15.4)
Yes 53.3 38.0 (34.1, 42.0) 11.9 (9.5, 14.8)
Glycemic medication use (%)
No 55.8 38.0 (34.6, 41.5) 11.8 (9.7, 14.4)
Yes 44.2 37.8 (34.0, 41.8) 12.4 (10.4, 14.8)
a Age standardized to 18–26, 27–35, 36–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74 years; chronic kidney disease, coronary heart disease, cerebrovascular disease, in-
termittent claudication, and ankle brachial index were age standardized to 45–49, 50–54, 55–59, 60–64, 65–69, 70–74 years.
b PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear.
c PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear and PTA(500, 1000, 2000) >25 dB in the worse ear.
§ Measured among participants 45–76 years.
CI = Conﬁdence Interval; eGFR = estimated glomerular ﬁltration rate.
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impairment among those with coronary heart disease, cerebrovas-
cular disease, or intermittent claudication. Sixty-three percent of
these Hispanic/Latino individuals were previously diagnosed with
diabetes; 60.8% had a family history of diabetes. Neither prior di-
agnosis nor family history of diabetes was associated with hearing
impairment. The age-standardized prevalence of high-frequency
hearing impairment among those with high ankle-brachial index
(ABI) was much greater than among those whose ABI was in the
normal range, but with only 1.6% of participants in this category,
power to detect a signiﬁcant difference was low.
Among the 2151 adults with previously diagnosed diabetes, one-
third had a diabetes duration of up to three years, and almost as
many (31.3%) had diabetes of over ten years duration. No signiﬁ-
cant difference in the prevalence of hearing impairment was
observed by duration of diabetes, glycemic control, or use of gly-
cemic medications.
Table 3 provides the frequency distributions of cardiovascular
disease risk factors and the age-standardized prevalence of hearing
impairment stratiﬁed by these factors. Over one-half of these dia-
betic adults were obese and three-quartersmet the criteria for central
adiposity. Anthropometric measures were not associated with
hearing impairment. A majority of these Hispanic/Latino adults with
diabetes had hypertension and almost one half had total choles-
terol ≥200 mg/dL. Almost one-half had low HDL-C and 69.3% had
LDL-C ≥ 100 mg/dL. One third was using lipid-lowering medica-
tion and two thirds had adverse cholesterol accounting for the use
of medications. Forty-seven percent had high triglycerides, and this
group had a higher prevalence of high-frequency hearing impair-
ment, although the conﬁdence intervals were overlapping.
Dyslipidemia, exhibited by 49.3% of these Hispanic/Latino diabet-
ic adults, was associated with a greater prevalence of high-frequency
hearing impairment. Behavioral risk factors were associated with
Table 3
Age-standardizeda weighted prevalence of hearing impairment among people with diabetes age 18–76 years by cardiovascular disease risk factors (Hispanic Community
Health Study/Study of Latinos, n = 3384)
Prevalence (95% CI)
Cardiovascular disease risk factors Weighted %
High-frequencyb
(n = 1870)
High-frequency plus
low/mid-frequencyc (n = 655)
BMI (%)
Normal 9.9 40.2 (31.7, 49.3) 11.4 (8.6, 15.0)
Overweight 33.7 34.3 (30.7, 38.0) 12.0 (9.5, 15.1)
Obese 56.4 39.7 (36.2, 43.2) 12.3 (10.1, 15.0)
Central adiposity (%)
No 25.2 40.2 (35.2, 45.4) 11.6 (9.3, 14.4)
Yes 74.8 37.9 (34.7, 41.1) 12.4 (10.3, 14.7)
Hypertension (%)
No 42.4 37.4 (34.3, 40.6) 10.9 (8.8, 13.6)
Yes 57.6 38.9 (33.4, 44.6) 11.7 (9.9, 13.9)
Total cholesterol, mg/dL (%)
<200 51.3 36.0 (33.0, 39.1) 13.4 (11.2, 16.0)
200–< 240 28.0 41.1 (35.0, 47.6) 10.4 (7.8, 13.7)
≥240 20.7 40.5 (33.5, 47.9) 12.3 (8.3, 17.8)
HDL-C, mg/dL (%)
≥ 40 (males) or ≥ 50 (females) 51.1 36.4 (33.1, 39.9) 11.2 (9.3, 13.3)
<40 (males) or <50 (females) 48.9 38.7 (35.1, 42.4) 13.0 (10.6, 15.7)
LDL-C, mg/dL (%)
<100 30.7 35.3 (31.7, 39.1) 12.2 (9.8, 15.0)
≥100–< 130 28.8 35.4 (31.2, 39.8) 13.6 (10.4, 17.6)
≥130–< 160 24.6 43.9 (36.7, 51.3) 10.3 (8.3, 12.8)
≥160 15.8 34.3 (28.3, 41.0) 10.4 (7.9, 13.7)
Lipid-lowering medications
No 66.3 38.6 (35.7, 41.6) 12.0 (10.2, 14.2)
Yes 33.7 34.0 (29.6, 38.6) 12.5 (9.3, 16.5)
Adverse cholesterol, includes lipid medication used
No 33.4 36.0 (32.5, 39.6) 10.7 (8.4, 13.6)
Yes 66.6 39.4 (35.8, 43.2) 12.9 (10.8, 15.4)
Triglycerides, mg/dL (%)
<150 53.4 34.5 (31.4, 37.8) 11.1 (9.2, 13.5)
≥ 150 46.6 42.0 (37.5, 46.5) 13.6 (11.0, 16.7)
Dyslipidemiae (%)
No 50.7 33.9 (31.0, 36.8) 10.4 (8.6, 12.7)
Yes 49.3 41.2 (37.4, 45.0) 14.2 (11.7, 17.1)
Cigarette use (%)
Never 56.1 35.6 (32.3, 39.2) 12.0 (9.9, 14.3)
Former 25.4 42.0 (36.3, 47.9) 9.6 (8.1, 11.4)
Current 18.6 39.8 (34.6, 45.4) 15.9 (11.9, 21.0)
Alcohol use, drinks/week (%)
0 23.7 38.7 (31.0, 47.1) 15.8 (10.1, 23.8)
1–13 (males) or 1–6 (females) 32.8 38.4 (34.1, 42.9) 9.0 (7.3, 11.1)
≥14 (males) or ≥7 (females) 4.4 48.4 (37.9, 59.0) 15.7 (10.6, 22.7)
Former drinker 39.1 35.7 (32.6, 38.8) 13.3 (11.1, 15.8)
a Age standardized to 18–26, 27–35, 36–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74 years.
b PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear.
c PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear and PTA(500, 1000, 2000) >25 dB in the worse ear.
d High cholesterol deﬁned as total cholesterol ≥ 240 mg.dL, LDL ≥160 md/dL, HDL ≤ 40 mg/dL, or lipid-lowering medication use.
e Dyslipidemia deﬁned as low HDL-C, high LDL-C, or high triglycerides.
CI = Conﬁdence Interval.
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the combined high plus low/mid-frequency hearing impairment. The
18.6% Hispanic/Latino diabetic adults who were current smokers
had a signiﬁcantly greater prevalence of the combined high plus low/
mid-frequency hearing impairment compared to former smokers.
The thirty-nine percent of people who formerly consumed alco-
holic beverages had a greater prevalence of high plus low/mid-
frequency hearing impairment than those who consumed alcohol
at levels consistent with a low risk of alcohol use disorder (<14 drinks
per week for males or <7 drinks per week for females).
Independent associations for high-frequency hearing impair-
ment and the combined (high- plus low/mid-frequency) hearing
impairment are presented as odds ratios and prevalence ratios with
corresponding conﬁdence intervals in Table 4. Current or former use
of cigarettes was associated with a 9–11% greater prevalence of high-
frequency hearing impairment than never smokers. Current smokers
had a 35% greater prevalence of the combined outcome than never
smokers. Men who consumed ≥14 alcoholic drinks/week or women
who consumed ≥7 alcoholic drinks/week were considered at high
risk category of developing an alcohol use disorder. People in this
category had a borderline increased prevalence of high-frequency
hearing impairment and a 64% greater prevalence of the high- plus
low/mid- frequency hearing impairment than those who con-
sumed alcohol at more modest levels. Triglycerides ≥150mg/dL was
not associated with high-frequency hearing impairment but was as-
sociated with a 29% greater prevalence of high-frequency plus low/
mid-frequency hearing impairment. Hispanic/Latino adults with
severe or end-stage chronic kidney disease had a greater preva-
lence but the conﬁdence intervals did not indicate a statistically
signiﬁcant difference from normal (PR1.30 (0.91, 1.87)). Hispanic/
Latinos with diabetes who had chronic kidney complications of
moderate severity had a 23% greater prevalence of high-frequency
hearing impairment than those with normal kidney function. Com-
pared with persons whose annual family income exceeded $40,000,
those with an annual family income level below $20,000 had a 14%
greater prevalence of high-frequency hearing impairment (PR 1.14
(1.01, 1.28)) and a 93% greater prevalence of high- plus low/mid-
frequency hearing impairment (PR 1.93 (1.34, 2.78)). Hispanic/
Latino adults with less than a high school education had 18% greater
and 27% greater prevalence of high-frequency and high and low/
mid-frequency hearing impairment, respectively, compared to those
who had some education beyond high school.
Discussion
We examined two indicators of loss of hearing sensitivity: high-
frequency hearing impairment and high-frequency in addition to
low/mid-frequency hearing impairment, among a cohort of Hispanic/
Latino adults with diabetes and identiﬁed cigarette smoking, high
levels of alcohol consumption and high triglyceride levels as po-
tentially modiﬁable factors associated with hearing impairment. We
also observed that participants who had lower family income and
lower educational attainment were more likely to have hearing im-
pairment. Diabetes severity, as indicated by diabetes duration,
suboptimal glycemic control, and use of glycemic medication were
not associated with hearing impairment.
Hyperglycemia has been longitudinally associated with inci-
dent hearing loss in general populations [11,12], but cross-sectional
analyses have not supported glycemia as a correlate of hearing im-
pairment among people with diabetes [8,9]. With well-characterized
relationships between glycemic control and microvascular compli-
cations of diabetes [27], we hypothesized that we would detect an
association in this large cohort of adults with diabetes, if glycemia
similarly affected the highly vascularized tissue of the inner ear. We
did not, however, observe an association with suboptimal glyce-
mic control (HbA1c ≥7%) indicating glycemia may not be causally
related to hearing loss among people with diabetes. Because HbA1c
indicates an average level of glycemia over the previous three
months, if hearing loss onset or its progression are related to gly-
cemia of longer duration or to episodic hyper- or hypoglycemia or
to glycemic variability over time, our single measure of HbA1c would
not have captured this variability. Cruickshanks et al. reported an
elevated risk of hearing impairment in a general population
Table 4
Independent associations between hearing impairment and its correlates among the HCHS-SOL sample with diabetes, age 18–76 years (n = 3384)
High-frequencya High-frequency plus low/mid-frequencyb
Odds Ratio (95% CI) Prevalence ratio (95% CI) Odds Ratio (95% CI) Prevalence ratio (95% CI)
Cigarette use
Never 1.00 1.00 1.00 1.00
Former 1.46 (1.09, 1.96) 1.11 (1.03, 1.21) 0.92 (0.66, 1.28) 0.94 (0.75, 1.19)
Current 1.35 (0.99, 1.85) 1.09 (1.00, 1.19) 1.61 (1.10, 2.37) 1.35 (1.07, 1.71)
Alcohol use, drinks/week
0 1.41 (0.97, 2.05) 1.10 (0.99, 1.22) 1.42 (0.94, 2.15) 1.28 (0.96, 1.71)
1–13 (males) or 1–6 (females) 1.00 1.00 1.00 1.00
≥14 (males) or ≥7 (females) 1.64 (0.93, 2.90) 1.15 (0.99, 1.32) 2.12 (1.16, 3.86) 1.64 (1.14, 2.38)
Former drinker 1.19 (0.90, 1.59) 1.05 (0.97, 1.15) 1.67 (1.20, 2.31) 1.42 (1.13, 1.78)
Triglycerides ≥ 150 mg/dL – – 1.46 (1.09, 1.97) 1.29 (1.06, 1.57)
Chronic kidney disease
Normal (eGFR ≥ 90 mL/min/1.73 m2) 1.00 1.00 – –
Mild (eGFR 60–89 mL/min/1.73 m2) 1.11 (0.84, 1.46) 1.03 (0.95, 1.12) – –
Moderate (eGFR 30–59 mL/min/1.73 m2) 2.28 (1.04, 5.02) 1.23 (1.04, 1.47) – –
Severe/End-Stage (eGFR< 30 mL/min/1.73 m2) 3.00 (0.44, 20.45) 1.30 (0.91, 1.87) – –
Annual family income, $
$20,000 or less 1.55 (1.07, 2.25) 1.14 (1.01, 1.28) 2.49 (1.57, 3.96) 1.93 (1.34, 2.78)
$20,000–$40,000 1.42 (0.98, 2.05) 1.11 (0.99, 1.25) 1.62 (1.01, 2.61) 1.44 (0.99, 2.08)
>$40,000 1.00 1.00 1.00 1.00
Educational level
Less than high school 1.39 (1.04, 1.85) 1.10 (1.01, 1.19) 1.43 (1.0, 2.1) 1.27 (0.99, 1.63)
High school 1.06 (0.77, 1.45) 1.02 (0.93, 1.12) 0.89 (0.57, 1.39) 0.92 (0.67, 1.27)
Greater than high school 1.00 1.00 1.00 1.00
a PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear – controlling for age and sex.
b PTA(3000, 4000, 6000, 8000 Hz) >25 dB in the worse ear and PTA(500, 1000, 2000) >25 dB in the worse ear -controlling for age, and Hispanic/Latino group.
CI = Conﬁdence Interval; eGFR = estimated glomerular ﬁltration rate.
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occurred at an HbA1c threshold ≥12.5% [12], thus it may be thatmore
severe glucose dysregulation is necessary for inducing elevated au-
diometric thresholds. Diabetes duration and use of glycemic
medications were not associated with hearing impairment in the
current study, ﬁndings consistent with previous cross-sectional and
longitudinal evidence [28,29].
Dalton et al. showed an association between severe diabetic ne-
phropathy (proteinuria, renal transplant or dialysis) and hearing loss
[9]. We used estimated glomerular ﬁltration rate as the indicator
of renal function and demonstrated that loss of hearing sensitivi-
ty is apparent at earlier stages of chronic kidney disease. This
observation adds to recent evidence from Korea where mild chronic
kidney disease (eGFR 60–90 mL/min/1.73 m2) was associated with
more severe hearing impairment [30]. Independent of diabetes, es-
timated glomerular ﬁltration rate less than 60 mL/min/1.73 m2 has
been associated with hearing loss of mild severity in population-
based studies conducted in Australia and Korea [10,31]. Reduced
kidney function was not associated with high plus low/mid-
frequency hearing loss in our study, a result that could be explained
by loss from the cohort due to the mortality of people with ad-
vanced kidney disease [32].
In this relatively young cohort with diabetes, we found no as-
sociations of hearing impairment with coronary heart disease or
cerebrovascular disease. As previously reported, current smoking
was not associated with hearing impairment in the HCHS/SOL
general population after adjusting for diabetes [2], yet when we
deﬁned hearing impairment in terms of both a high-frequency and
a low/mid-frequency component, we found a greater prevalence
among people with diabetes who smoke. Smoking has been linked
to prevalent and incident hearing loss, among general popula-
tions [12,33], but the associations are not necessarily strong [34].
Our observations add to evidence that the toxic effects of smoking
lead to hearing loss. Similarly, we documented a positive associa-
tion between high triglycerides and high plus low/mid-frequency
hearing impairment, evidence that agree with other cross-sectional
studies [35,36]. The identiﬁcation of an association between hearing
impairment and atherogenic risk factors, such as smoking and tri-
glycerides, lends credence to a vascular etiology for hearing loss.
Thickened capillaries observed within the stria vascularis [37] and
sclerosis of the internal auditory artery [38] among people known
to have had diabetes provide pathophysiologic evidence of
injury to the cochlea, the inner ear organ responsible for translat-
ing sound waves to nerve impulses for transmission to the brain.
We infer from our ﬁndings that smoking and dyslipidemia may be
markers of a progressive, atherosclerotic mechanism, possibly related
to lipid oxidation, that damages the cochlea and reduces hearing
sensitivity.
Moderate alcohol use has been associated with lower preva-
lence of hearing loss [39]. We found that alcohol consumption at
higher levels is positively associated with hearing impairment con-
sistent with recent evidence from a nationally representative sample
of Korean adults [40]. With our large sample of diabetic adults, we
were able to separate former drinkers from lifelong abstainers; we
found a J-shaped association between alcohol consumption and
hearing loss similar to what has been consistently reported between
alcohol and heart disease [41]. This so-called cardioprotective effect
of moderate alcohol consumption is thought to be related to de-
creased lipid oxidation. The association we report persists
after controlling for dyslipidemia and may reﬂect a different
mechanism.
We found family income and educational level were indepen-
dently and negatively associated with both high-frequency and high
plus low/mid-frequency hearing impairment. A previous examina-
tion of risk factors for hearing impairment among adults with
diabetes found those with lower education had a higher preva-
lence of hearing loss but the association was not independent of
diabetic complications including coronary heart disease, peripher-
al neuropathy, and reported poor health [8]. Rather, the social
patterning observed in the present analysis is consistent with a lower
likelihood of hearing impairment as education and income level in-
crease among the general population in the Hispanic communities
from which the sample was drawn [2]. More research is needed to
determine what factors predispose people of lower socio-economic
position to greater risk of hearing impairment [42].
Our analysis has limitations including the inability to distin-
guish type 1 from type 2 diabetes and no available data with
which to test a neuropathic mechanism for hearing loss. Infer-
ences regarding the temporal relationships between the covariates
and hearing impairment are limited by the cross-sectional nature
of the data. We undoubtedly have some errors in measurement.
Cigarette and alcohol use are by self-report and are subject to
recall bias, a bias unlikely to be differential with respect to
hearing impairment. Last, ﬁndings from this cohort of community-
dwelling Hispanic/Latinos within speciﬁc geographically-deﬁned
areas may not be generalizable to other demographic groups,
including other Hispanic/Latino populations, within or outside
the U.S.
Hearing impairment was experienced by 59.3% of these Hispanic/
Latino adults with diabetes. Those who have lower family income
and lower education are more likely to be affected. Hearing im-
pairment was detected among people with earlier stages of diabetic
nephropathy than previously documented. Our ﬁndings suggest an
emphasis on smoking cessation, reduction of high levels of alcohol
consumption, and lipid management may offer opportunities to
lower the public health burden of hearing impairment among
Hispanic/Latinos with diabetes.
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